ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
11 hedge funds and large institutions have $3.43M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
27% less funds holding
Funds holding: 15 → 11 (-4)
49% less capital invested
Capital invested by funds: $6.69M → $3.43M (-$3.25M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$526K |
| 2 |
Renaissance Technologies
New York
|
+$110K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$38K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$195K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$164K |
| 3 |
Two Sigma Investments
New York
|
-$61K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$60K |
| 5 |
Morgan Stanley
New York
|
-$10.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Temasek Holdings
Singapore
| $1.45M | – | – | – |
|
|
SCM
2
Sio Capital Management
New York
| $1.32M | +$526K | +6,924 | +27% |
|
|
PIM
3
Platinum Investment Management
Sydney Australia 2000,
Australia
| $424K | – | – | – |
|
|
DCM
4
DAFNA Capital Management
Los Angeles,
California
| $88K | -$60K | -790 | -27% |
|
|
5
Renaissance Technologies
New York
| $77K | +$110K | +1,444 | +332% |
|
|
6
Bank of Montreal
Toronto,
Ontario, Canada
| $30K | +$38K | +500 | +200% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $23K | +$21.9K | +289 | +103% |
|
|
8
Morgan Stanley
New York
| $13K | -$10.9K | -143 | -31% |
|
|
9
UBS Group
Zurich,
Switzerland
| $4K | +$7.29K | +96 | +2,400% |
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | -$1.82K | -24 | -44% |
|
|
11
Marshall Wace
London,
United Kingdom
| – | -$195K | -2,402 | Closed |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | -$164K | -2,019 | Closed |
|
|
13
Two Sigma Investments
New York
| – | -$61K | -747 | Closed |
|
14
Barclays
London,
United Kingdom
| – | -$152 | -2 | -29% |
|
ASLN Hedge Fund Activity: Q1 2020 in Review
11 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q1 2020, worth a combined $3.43M — down 49% from $6.69M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ASLN and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Sio Capital Management, adding an estimated $526K. The largest seller was Marshall Wace, exiting entirely with an estimated $195K sold.
- 11 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q1 2020, down from 15 in Q4 2019.
- Funds reported $3.43M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q1 2020, down 49% quarter-over-quarter.
- 0 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q1 2020 and 3 closed out, a net change of -3 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q1 2020 was Sio Capital Management, an estimated $526K added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q1 2020 was Marshall Wace, an estimated $195K sold.
Based on aggregated 13F filings for Q1 2020.